C4 Therapeutics, Inc.: net_income
| Value | {"amount": -66335000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | current |
| Entity | C4 Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:06:02.697479+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/fc160c0c-9bb8-4cb0-bbee-1bb296c32ed8
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-21-012531Retrieved: 2026-08-19T17:06:02.697479+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001662579/net-income/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/fc160c0c-9bb8-4cb0-bbee-1bb296c32ed8
History
- no predecessors — first report